| Country | Type | Number | Dated | Case |
| United States Of America | Issued Patent | 12,241,902 | 03/04/2025 | 2019-129 |
Biomedical Research: Mapping the distribution and movement of copper ions in cellular models to study the underlying mechanisms of neurodegenerative disorders, such as Alzheimer's disease, Wilson's disease, and Menkes disease.
Diagnostic Assays: Developing high-throughput screening tools to identify abnormal copper regulation and transport defects in patient tissue samples.
Drug Discovery: Testing candidate pharmaceuticals to evaluate their efficacy in correcting metal imbalances or mitigating heavy metal toxicity inside living cells.
Environmental Toxicology: Assessing the biological impact and toxicity profiles of environmental copper contamination on human and animal cell models.
Nutritional Studies: Investigating how dietary factors and supplements influence the absorption and intracellular bio-availability of essential copper nutrients.
High Specificity: Distinctly responds to monovalent copper ions while remaining unaffected by other abundant intracellular metal ions such as zinc, iron, or calcium, minimizing false-positive readings. Live-Cell Compatibility: Enables real-time, non-destructive visualization of metal fluctuations within active living structures rather than requiring fixed or destroyed cell samples. Ratiometric Readout: Capitalizes on the Förster resonance energy transfer mechanism to provide a ratio-based signal, which naturally corrects for variations in probe concentration, cell thickness, and laser intensity. Exceptional Sensitivity: Capable of detecting trace physiological concentrations of copper, providing highly precise measurements even in low-abundance cellular compartments. Membrane Permeability: Engineered to easily pass through cellular membranes while exhibiting low toxicity, ensuring the probe integrates smoothly into standard cell culture workflows.
fluorescent, copper probe, oxidative stress, cancer, ratiometric, activity-based sensing